Subsequent studies also considered other categories of tumors with evidences of homologous recombination deficiency (HRD), e.g., cancers with somatic inactivation of BRCA1/2, or tumors driven by mutations in other genes of DNA repair pathways, or neoplasms characterized by high-level chromosomal instability. The gene discussed is BRCA1; the disease is cancer.